1. Home
  2. AFCG vs MDWD Comparison

AFCG vs MDWD Comparison

Compare AFCG & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AFCG
  • MDWD
  • Stock Information
  • Founded
  • AFCG 2020
  • MDWD 2000
  • Country
  • AFCG United States
  • MDWD Israel
  • Employees
  • AFCG N/A
  • MDWD N/A
  • Industry
  • AFCG Real Estate Investment Trusts
  • MDWD Medicinal Chemicals and Botanical Products
  • Sector
  • AFCG Real Estate
  • MDWD Health Care
  • Exchange
  • AFCG Nasdaq
  • MDWD Nasdaq
  • Market Cap
  • AFCG 189.9M
  • MDWD 184.8M
  • IPO Year
  • AFCG 2021
  • MDWD 2014
  • Fundamental
  • Price
  • AFCG $7.91
  • MDWD $17.68
  • Analyst Decision
  • AFCG Buy
  • MDWD Strong Buy
  • Analyst Count
  • AFCG 6
  • MDWD 1
  • Target Price
  • AFCG $12.00
  • MDWD $25.00
  • AVG Volume (30 Days)
  • AFCG 112.5K
  • MDWD 66.3K
  • Earning Date
  • AFCG 03-13-2025
  • MDWD 03-20-2025
  • Dividend Yield
  • AFCG 18.29%
  • MDWD N/A
  • EPS Growth
  • AFCG N/A
  • MDWD N/A
  • EPS
  • AFCG 0.40
  • MDWD N/A
  • Revenue
  • AFCG $43,164,939.00
  • MDWD $19,720,000.00
  • Revenue This Year
  • AFCG N/A
  • MDWD $10.15
  • Revenue Next Year
  • AFCG N/A
  • MDWD $25.62
  • P/E Ratio
  • AFCG $21.55
  • MDWD N/A
  • Revenue Growth
  • AFCG N/A
  • MDWD N/A
  • 52 Week Low
  • AFCG $7.45
  • MDWD $12.78
  • 52 Week High
  • AFCG $10.88
  • MDWD $24.00
  • Technical
  • Relative Strength Index (RSI)
  • AFCG 31.84
  • MDWD 43.90
  • Support Level
  • AFCG $8.06
  • MDWD $18.01
  • Resistance Level
  • AFCG $8.88
  • MDWD $19.13
  • Average True Range (ATR)
  • AFCG 0.22
  • MDWD 0.91
  • MACD
  • AFCG -0.00
  • MDWD -0.14
  • Stochastic Oscillator
  • AFCG 10.19
  • MDWD 21.37

About AFCG AFC Gamma Inc.

Advanced Flower Capital Inc is a commercial mortgage REIT that provides institutional loans to state-law-compliant cannabis operators in the U.S. Through the management team's deep network and significant credit and cannabis expertise, AFC originates, structures and underwrites loans ranging from $10 million to over $100 million, typically secured by quality real estate assets, license value and cash flows.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: